| Anomalous behaviour of the STAT3 binding site in the human c-myc P2 promoter. Vougier S., Cheung S.H., Li L., Hodgson G., Shaw P.E.
Biochem. Biophys. Res. Commun. 364:627-632(2007) · Mapped (15) |
| Evaluation of role of G-CSF in the production, survival, and release of neutrophils from bone marrow into circulation. Basu S., Hodgson G., Katz M., Dunn A.R.
Blood 100:854-861(2002) · Mapped (3) |
| The genome sequence of Schizosaccharomyces pombe. Wood V., Gwilliam R., Rajandream M.A., Lyne M.H., Lyne R., Stewart A., Sgouros J.G., Peat N., Hayles J., Baker S.G. et al.
Nature 415:871-880(2002) · UniProtKB (4,962) |
| Gain- and loss-of-function Lyn mutant mice define a critical inhibitory role for Lyn in the myeloid lineage. Harder K.W., Parsons L.M., Armes J., Evans N., Kountouri N., Clark R., Quilici C., Grail D., Hodgson G.S., Dunn A.R. et al.
Immunity 15:603-615(2001) · Mapped (5) |
| "Emergency" granulopoiesis in G-CSF-deficient mice in response to Candida albicans infection. Basu S., Hodgson G., Zhang H.H., Katz M., Quilici C., Dunn A.R.
Blood 95:3725-3733(2000) · Mapped (10) |
| Mice lacking both granulocyte colony-stimulating factor (CSF) and granulocyte-macrophage CSF have impaired reproductive capacity, perturbed neonatal granulopoiesis, lung disease, amyloidosis, and reduced long-term survival. Seymour J.F., Lieschke G.J., Grail D., Quilici C., Hodgson G., Dunn A.R.
Blood 90:3037-3049(1997) · Mapped (6) |
| Increased tolerance to endotoxin by granulocyte-macrophage colony-stimulating factor-deficient mice. Basu S., Dunn A.R., Marino M.W., Savoia H., Hodgson G., Lieschke G.J., Cebon J.
J. Immunol. 159:1412-1417(1997) · Mapped (3) |
| Granulocyte/macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology. Stanley E., Lieschke G.J., Grail D., Metcalf D., Hodgson G., Gall J.A., Maher D.W., Cebon J., Sinickas V., Dunn A.R.
Proc. Natl. Acad. Sci. U.S.A. 91:5592-5596(1994) · Mapped (3) |
| Mice lacking both macrophage- and granulocyte-macrophage colony-stimulating factor have macrophages and coexistent osteopetrosis and severe lung disease. Lieschke G.J., Stanley E., Grail D., Hodgson G., Sinickas V., Gall J.A., Sinclair R.A., Dunn A.R.
Blood 84:27-35(1994) · Mapped (8) |
| Granulocyte-macrophage colony-stimulating factor is not responsible for the correction of hematopoietic deficiencies in the maturing op/op mouse. Nilsson S.K., Lieschke G.J., Garcia-Wijnen C.C., Williams B., Tzelepis D., Hodgson G., Grail D., Dunn A.R., Bertoncello I.
Blood 86:66-72(1995) · Mapped (8) |
| Multiple defects in the immune system of Lyn-deficient mice, culminating in autoimmune disease. Hibbs M.L., Tarlinton D.M., Armes J., Grail D., Hodgson G., Maglitto R., Stacker S.A., Dunn A.R.
Cell 83:301-311(1995) · Mapped (5) |
| Mice lacking granulocyte colony-stimulating factor have chronic neutropenia, granulocyte and macrophage progenitor cell deficiency, and impaired neutrophil mobilization. Lieschke G.J., Grail D., Hodgson G., Metcalf D., Stanley E., Cheers C., Fowler K.J., Basu S., Zhan Y.F., Dunn A.R.
Blood 84:1737-1746(1994) · Mapped (3) |
| Yeast phosphoglycerate mutate. Cyanogen bromide cleavage and amino acid sequence of an active-site peptide. Fothergill L.A., Hodgson G.I.
Biochem. J. 153:145-149(1976) · Mapped (1) |
in Literature Citations
